Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 18
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

Human Endogenous Retroviruses (HERVs) are ancient sequences that became integrated into our DNA during evolutionary processes.

The significance of their presence in DNA is still being studied, but HERVs appear to be involved in the regulation of the immune response.

The gut microbiota is the set of microorganisms that physiologically colonize the gastrointestinal tract. Progressively increasing attention is being paid to the gut microbiota and its potential role in diseases of various kinds. In particular, it has recently been shown how abnormalities in the microbiota can affect immune regulation by determining the occurrence of certain diseases. One objective of the study is to evaluate whether there is an association between the expression of HERVs and clinical manifestations in pediatric age in patients with various diseases such as Kawasaki Disease, IgA Vasculitis/Schonlein-Henoch's Purpura, SARS-CoV-2 infection, or, finally, febrile virosis.

Another objective of the study is to evaluate whether there is an association between the presence of particular types of bacteria in the gut microbiota and clinical manifestations in pediatric age in patients with Kawasaki Disease, IgA Vasculitis/Schonlein-Henoch purpura, SARS-CoV-2 infection or febrile virosis.

The results from this may open new perspectives for both the care and therapeutic management of children with these diseases.

Eligibility criteria

Qualifiers

Pediatric patients, newly diagnosed with Kawasaki disease

Pediatric patients, newly diagnosed with Vasculitis

Pediatric patients, newly diagnosed with SARS-CoV-2 infection

Pediatric patients, newly diagnosed with febrile virosis

Disqualifiers

None

Trial design

Treatments tested in this trial

  • sample collection

Treatment groups

120 Participants
are divided into 1 treatment group